Provided by Tiger Trade Technology Pte. Ltd.

OptimizeRx Corporation

8.57
+0.18002.15%
Post-market: 8.570.00000.00%19:30 EDT
Volume:224.86K
Turnover:1.94M
Market Cap:160.77M
PE:34.83
High:8.76
Open:8.55
Low:8.31
Close:8.39
52wk High:22.25
52wk Low:4.54
Shares:18.76M
Float Shares:14.50M
Volume Ratio:0.90
T/O Rate:1.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2461
EPS(LYR):0.2700
ROE:3.68%
ROA:4.22%
PB:1.23
PE(LYR):31.74

Loading ...

B. Riley Raises Price Target on OptimizeRx to $11 From $10, Keeps Buy Rating

MT Newswires Live
·
Sep 29

OptimizeRx Integrates with Trade Desk OpenPath to Offer Authenticated EHR Ad Inventory

Reuters
·
Sep 22

OptimizeRx Expands Natural Language Audience Builder to Add DTC Targeting Workflow

Reuters
·
Sep 14

OptimizeRx Management Participates in Lake Street Capital Best Ideas Growth Conference

Reuters
·
Sep 08

Press Release: OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor

Dow Jones
·
Sep 02

OptimizeRx names Andy D’Silva CFO, Heather Favazza chief accounting officer

TIPRANKS
·
Aug 17

OptimizeRx is Maintained at Market Outperform by Citizens

Dow Jones
·
Aug 14

Marpai Q2 Revenue Falls Due to Turnover and Continued Customer Pruning

Reuters
·
Aug 14

Lake Street Sticks to Their Buy Rating for OptimizeRx (OPRX)

TIPRANKS
·
Aug 13

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 13

Optimizerx Announces Finance Leadership Appointments to Support the Next Phase of Growth

Reuters
·
Aug 13

OptimizeRx Corporation Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

OptimizeRx Reaffirms 2026 Outlook Amid Revenue Decline

TIPRANKS
·
Aug 13

OptimizeRx Names Andy D'Silva CFO Effective Jan. 1, 2027

Reuters
·
Aug 13

OptimizeRx Q2 Revenue Beats Estimates on Operating Resilience; Reaffirms Outlook

Reuters
·
Aug 13

OptimizeRx Q2 Adj. EPS $0.16 Beats $0.12 Estimate, Sales $20.504M Beat $20.204M Estimate

Benzinga Earnings
·
Aug 13

OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth

THOMSON REUTERS
·
Aug 13

OptimizeRx Corporation - Appoints Andy D’silva as CFO and Heather Favazza as Chief Accounting Officer Effective Jan 1, 2027

THOMSON REUTERS
·
Aug 13

OptimizeRx Q2 GAAP Net Loss Narrows to $0.7 Million; Revenue Drops 30% to $20.5 Million Year over Year

Reuters
·
Aug 13

OPTIMIZERx Q2 Revenue USD 20.5 Million Vs. IBES Estimate USD 20.2 Million

Reuters
·
Aug 13